$LCTX
Lineage Cell Therapeutics, Inc.

2024 Q1 Form 10-K Financial Statement

#000095017024027988 Filed on March 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $1.444M $2.088M $8.945M
YoY Change -39.83% 9.03% -39.15%
Cost Of Revenue $98.00K $256.0K $671.0K
YoY Change -17.65% 150.98% -7.83%
Gross Profit $1.346M $1.832M $8.274M
YoY Change -40.63% 1.05% -40.79%
Gross Profit Margin 93.21% 87.74% 92.5%
Selling, General & Admin $4.997M $4.288M $17.30M
YoY Change 5.78% -1.38% -23.13%
% of Gross Profit 371.25% 234.06% 209.11%
Research & Development $3.010M $3.906M $15.61M
YoY Change -28.08% -4.82% 11.57%
% of Gross Profit 223.63% 213.21% 188.6%
Depreciation & Amortization $175.0K $175.0K $692.0K
YoY Change 26.81% 1.16% 18.9%
% of Gross Profit 13.0% 9.55% 8.36%
Operating Expenses $3.010M $8.194M $33.01M
YoY Change -66.21% -3.05% -9.56%
Operating Profit -$6.661M -$6.362M -$24.73M
YoY Change 0.29% -4.17% 9.83%
Interest Expense $462.0K $398.0K $1.453M
YoY Change 2.67% -423.58% -206.45%
% of Operating Profit
Other Income/Expense, Net $103.0K $1.250M -$2.000K
YoY Change -76.32% 212.5% -99.94%
Pretax Income -$6.558M -$4.714M -$23.28M
YoY Change 5.65% -25.9% -9.8%
Income Tax $0.00 $0.00 -$1.803M
% Of Pretax Income
Net Earnings -$6.542M -$4.775M -$21.49M
YoY Change 49.63% -24.85% -18.22%
Net Earnings / Revenue -453.05% -228.69% -240.2%
Basic Earnings Per Share -$0.04 -$0.03 -$0.12
Diluted Earnings Per Share -$0.04 -$0.03 -$0.12
COMMON SHARES
Basic Shares Outstanding 188.5M 175.0M shares 172.7M
Diluted Shares Outstanding 182.9M 172.7M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $43.62M $35.49M $35.49M
YoY Change -6.82% -38.67% -38.67%
Cash & Equivalents $43.58M $35.44M $35.44M
Short-Term Investments $45.00K $50.00K $50.00K
Other Short-Term Assets $2.018M $2.204M $2.204M
YoY Change -23.5% 20.57% 20.57%
Inventory
Prepaid Expenses
Receivables $77.00K $745.0K $745.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $45.72M $38.44M $38.44M
YoY Change -7.93% -35.93% -35.93%
LONG-TERM ASSETS
Property, Plant & Equipment $2.104M $4.767M $4.767M
YoY Change -62.32% -15.97% -15.97%
Goodwill $10.67M $10.67M
YoY Change 0.0% 0.0%
Intangibles $46.54M $46.56M
YoY Change -0.26% -0.28%
Long-Term Investments
YoY Change
Other Assets $596.0K $577.0K $577.0K
YoY Change -6.14% -7.97% -7.97%
Total Long-Term Assets $62.77M $62.58M $62.58M
YoY Change -1.23% -1.71% -1.71%
TOTAL ASSETS
Total Short-Term Assets $45.72M $38.44M $38.44M
Total Long-Term Assets $62.77M $62.58M $62.58M
Total Assets $108.5M $101.0M $101.0M
YoY Change -4.17% -18.31% -18.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.211M $2.050M $2.050M
YoY Change -26.32% -14.33% -14.33%
Accrued Expenses $991.0K $5.050M $5.050M
YoY Change 145.3% 31.75% -29.18%
Deferred Revenue $10.10M $10.80M
YoY Change -72.4% -72.09%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $49.00K $52.00K $52.00K
YoY Change -3.92% 44.44% 44.44%
Total Short-Term Liabilities $16.89M $17.96M $17.96M
YoY Change -1.94% -5.38% -5.38%
LONG-TERM LIABILITIES
Long-Term Debt $79.00K $91.00K $91.00K
YoY Change -40.6% 8.33% 8.33%
Other Long-Term Liabilities $20.25M $20.67M $20.67M
YoY Change 1033500.0% -32.42%
Total Long-Term Liabilities $20.33M $20.76M $20.76M
YoY Change 1038050.0% -32.3%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.89M $17.96M $17.96M
Total Long-Term Liabilities $20.33M $20.76M $20.76M
Total Liabilities $37.49M $37.60M $37.60M
YoY Change -15.16% -27.31% -25.29%
SHAREHOLDERS EQUITY
Retained Earnings -$391.4M -$384.9M
YoY Change 6.43% 5.91%
Common Stock $466.6M $451.3M
YoY Change 5.73% 2.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $72.40M $63.42M $63.42M
YoY Change
Total Liabilities & Shareholders Equity $108.5M $101.0M $101.0M
YoY Change -4.17% -18.31% -18.31%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$6.542M -$4.775M -$21.49M
YoY Change 49.63% -24.85% -18.22%
Depreciation, Depletion And Amortization $175.0K $175.0K $692.0K
YoY Change 26.81% 1.16% 18.9%
Cash From Operating Activities -$5.783M -$6.019M -$28.57M
YoY Change -48.56% -27.51% -2797.45%
INVESTING ACTIVITIES
Capital Expenditures $38.00K $91.00K $674.0K
YoY Change -79.79% -668.75% 63.2%
Acquisitions
YoY Change
Other Investing Activities $0.00 $9.833M $47.12M
YoY Change -100.0% -292.13% -203.01%
Cash From Investing Activities -$38.00K $9.742M $46.45M
YoY Change -100.25% -290.94% -200.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $6.713M
YoY Change 4435.81%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 14.02M -13.00K 6.423M
YoY Change 1402000.0% -110.66% 293.57%
NET CHANGE
Cash From Operating Activities -5.783M -6.019M -28.57M
Cash From Investing Activities -38.00K 9.742M 46.45M
Cash From Financing Activities 14.02M -13.00K 6.423M
Net Change In Cash 8.130M 3.710M 24.31M
YoY Change 99.02% -127.93% -154.82%
FREE CASH FLOW
Cash From Operating Activities -$5.783M -$6.019M -$28.57M
Capital Expenditures $38.00K $91.00K $674.0K
Free Cash Flow -$5.821M -$6.110M -$29.24M
YoY Change -49.07% -26.27% -4626.32%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0000876343
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
CY2022 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
CY2022Q4 lctx Deferred Tax Asset Operating Lease Liability
DeferredTaxAssetOperatingLeaseLiability
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
CY2023Q4 lctx Other Finance Lease Liabilities Current
OtherFinanceLeaseLiabilitiesCurrent
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-12830
CY2023 dei Entity Registrant Name
EntityRegistrantName
Lineage Cell Therapeutics, Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CA
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3127919
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
2173 Salk Avenue
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 200
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Carlsbad
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92008
CY2023 dei City Area Code
CityAreaCode
442
CY2023 dei Local Phone Number
LocalPhoneNumber
287-8990
CY2023 dei Security12b Title
Security12bTitle
Common shares
CY2023 dei Trading Symbol
TradingSymbol
LCTX
CY2023 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
185600000
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
188533536
CY2023 dei Auditor Name
AuditorName
WithumSmith+Brown, PC
CY2023 dei Auditor Location
AuditorLocation
San Francisco, California
CY2023 dei Auditor Firm
AuditorFirmId
100
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35442000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11355000
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
50000
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
46520000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
745000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
297000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2204000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1828000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
38441000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
60000000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4767000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5673000
CY2023Q4 lctx Deposits And Other Longterm Assets Non Current
DepositsAndOtherLongtermAssetsNonCurrent
577000
CY2022Q4 lctx Deposits And Other Longterm Assets Non Current
DepositsAndOtherLongtermAssetsNonCurrent
627000
CY2023Q4 us-gaap Goodwill
Goodwill
10672000
CY2022Q4 us-gaap Goodwill
Goodwill
10672000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
46562000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
46692000
CY2023Q4 us-gaap Assets
Assets
101019000
CY2022Q4 us-gaap Assets
Assets
123664000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6270000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
8608000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
830000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
916000
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
52000
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
36000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8945000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14703000
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
10808000
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
9421000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
17960000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18981000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
273000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2076000
CY2023Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
18693000
CY2022Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
27725000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1979000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2860000
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
91000
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
84000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2000
CY2023Q4 us-gaap Liabilities
Liabilities
38996000
CY2022Q4 us-gaap Liabilities
Liabilities
51728000
CY2023Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2022Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
174987000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
174987000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
170093000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
170093000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
451343000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
440280000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3068000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3571000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-384856000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-363370000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
63419000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
73339000
CY2023Q4 us-gaap Minority Interest
MinorityInterest
-1396000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
-1403000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
62023000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
71936000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
101019000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
123664000
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
671000
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
728000
CY2023 us-gaap Gross Profit
GrossProfit
8274000
CY2022 us-gaap Gross Profit
GrossProfit
13975000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15705000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13987000
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17302000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22508000
CY2023 us-gaap Operating Expenses
OperatingExpenses
33007000
CY2022 us-gaap Operating Expenses
OperatingExpenses
36495000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-24733000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-22520000
CY2023 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1629000
CY2022 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
829000
CY2023 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-176000
CY2022 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-2194000
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2000
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-225000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2152000
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1451000
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3292000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23282000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25812000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1803000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
541000
CY2023 us-gaap Profit Loss
ProfitLoss
-21479000
CY2022 us-gaap Profit Loss
ProfitLoss
-26353000
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
7000
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-80000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-21486000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-26273000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
172663000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
172663000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
169792000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
169792000
CY2023 us-gaap Profit Loss
ProfitLoss
-21479000
CY2022 us-gaap Profit Loss
ProfitLoss
-26353000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
353000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1790000
CY2023 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
150000
CY2022 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-150000
CY2023 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-20976000
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-24713000
CY2023 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
7000
CY2022 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-80000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20983000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-24633000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
90898000
CY2022 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
17000
CY2022 lctx Adjustments To Common Stock Share Based Compensation Requisite Service Period Recognition Value
AdjustmentsToCommonStockShareBasedCompensationRequisiteServicePeriodRecognitionValue
4287000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
490000
CY2022 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
991000
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-150000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1790000
CY2022 us-gaap Profit Loss
ProfitLoss
-26353000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
71936000
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6625000
CY2023 lctx Financing Related Fees
FinancingRelatedFees
-221000
CY2023 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
37000
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
56000
CY2023 lctx Adjustments To Common Stock Share Based Compensation Requisite Service Period Recognition Value
AdjustmentsToCommonStockShareBasedCompensationRequisiteServicePeriodRecognitionValue
4640000
CY2023 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
150000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
353000
CY2023 us-gaap Profit Loss
ProfitLoss
-21479000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
62023000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-21486000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-26273000
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
7000
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-80000
CY2023 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-176000
CY2022 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-2194000
CY2023 lctx Accretion Of Income On Marketable Debt Securities
AccretionOfIncomeOnMarketableDebtSecurities
679000
CY2022 lctx Accretion Of Income On Marketable Debt Securities
AccretionOfIncomeOnMarketableDebtSecurities
501000
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
562000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
582000
CY2023 lctx Change In Rightofuse Assets And Liabilities
ChangeInRightofuseAssetsAndLiabilities
91000
CY2022 lctx Change In Rightofuse Assets And Liabilities
ChangeInRightofuseAssetsAndLiabilities
-35000
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
130000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
145000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
4640000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
4287000
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2000
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-225000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1803000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-602000
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2272000
CY2023 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0
CY2022 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
11000
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
446000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-50314000
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
418000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-446000
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2295000
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-18702000
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-7645000
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-13354000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28566000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1059000
CY2023 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
196000
CY2022 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0
CY2023 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
16403000
CY2022 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
53412000
CY2023 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
63330000
CY2022 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
7666000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
674000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
413000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
46449000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-46159000
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
88000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
648000
CY2023 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
37000
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
17000
CY2023 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
991000
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6625000
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
148000
CY2023 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
199000
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
106000
CY2023 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
54000
CY2022 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
32000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6423000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1632000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-250000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-873000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
24056000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-44341000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11936000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
56277000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35992000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11936000
CY2023 us-gaap Interest Paid Net
InterestPaidNet
10000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
13000
CY2023 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
8000
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
28000
CY2023 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
22000
CY2022 lctx Receivable From Exercise Of Stock Options
ReceivableFromExerciseOfStockOptions
32000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35442000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11355000
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
550000
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
581000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35992000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11936000
CY2023 us-gaap Proceeds From Collaborators
ProceedsFromCollaborators
14300000
CY2023Q4 lctx Cash And Cash Equivalents And Marketable Securities
CashAndCashEquivalentsAndMarketableSecurities
35500000
CY2023Q4 us-gaap Marketable Securities
MarketableSecurities
100000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
700000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
300000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
100000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
100000
CY2023Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
21000000
CY2022Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
4100000
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
100000
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
100000
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentrations of credit risk and significant sources of supply</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> – Financial instruments that potentially subject Lineage to significant concentrations of credit risk consist primarily of cash, cash equivalents and marketable debt securities. Lineage limits the amount of credit exposure of cash balances by maintaining its accounts in high credit quality financial institutions. Cash equivalent deposits with financial institutions may occasionally exceed the limits of insurance on bank deposits; however, Lineage has not experienced any losses on such accounts. Lineage mitigates its credit exposure on marketable debt securities by investing in short term U.S. Treasuries securities.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Lineage relies on single-source, third-party suppliers for a few key components of our product candidates. If these single-source, third-party suppliers are unable to continue providing a key component, the initiation or progress of any clinical studies of its product candidates may be impeded.</span></p>
CY2022Q4 lctx Accounts Receivable Net Current Excludes Scope Of Asu201409
AccountsReceivableNetCurrentExcludesScopeOfAsu201409
297000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
37146000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
50500000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
29501000
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2023 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7588000
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
13367000
CY2023 lctx Royalties License And Other Revenues
RoyaltiesLicenseAndOtherRevenues
1357000
CY2022 lctx Royalties License And Other Revenues
RoyaltiesLicenseAndOtherRevenues
1336000
CY2023 us-gaap Revenues
Revenues
8945000
CY2022 us-gaap Revenues
Revenues
14703000
CY2022Q4 lctx Accounts Receivable Net Current Excludes Scope Of Asu201409
AccountsReceivableNetCurrentExcludesScopeOfAsu201409
297000
CY2021Q4 lctx Accounts Receivable Net Current Excludes Scope Of Asu201409
AccountsReceivableNetCurrentExcludesScopeOfAsu201409
50640000
CY2023Q4 lctx Accounts Receivable Net Current Excludes Scope Of Asu201409
AccountsReceivableNetCurrentExcludesScopeOfAsu201409
676000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
400000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1800000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
2700000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
3100000
CY2023 us-gaap Foreign Currency Transaction Gain Loss After Tax
ForeignCurrencyTransactionGainLossAfterTax
-500000
CY2022 us-gaap Foreign Currency Transaction Gain Loss After Tax
ForeignCurrencyTransactionGainLossAfterTax
-2000000
CY2023 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2022 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
37146000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
10800000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
9400000
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
46000000
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
8855000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
8856000
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
46247000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
152000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
46097000
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
8855000
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
8856000
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
8855000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
8856000
CY2023 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-176000
CY2022 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-2194000
CY2023 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-23000
CY2023 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-153000
CY2022 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-2194000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7238000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5850000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4767000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5673000
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
562000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
582000
CY2023 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
50000
CY2022 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
14000
CY2023Q4 us-gaap Goodwill
Goodwill
10672000
CY2022Q4 us-gaap Goodwill
Goodwill
10672000
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
66143000
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
66143000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
19581000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
19451000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
46562000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
46692000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
22000
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2050000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2393000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3123000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2382000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1097000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3833000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6270000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
8608000
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
29935000
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
50622000
CY2022Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
2000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2023Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
174986671
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
174986671
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
170093114
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
170093114
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
10824000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.42
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1.09
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0.85
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
1.5
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1.11
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M12D
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M15D
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.042
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.024
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.747
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.737
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4640000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4287000
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
8600000
CY2023 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y6M
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
38000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
367000
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
3947000
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
4122000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1800000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
500000
CY2022Q4 lctx Deferred Tax Asset Capitalized Research Expense
DeferredTaxAssetCapitalizedResearchExpense
3066000
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1707000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2555000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23282000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25812000
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
-0.01
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.03
CY2023 lctx Effective Income Tax Rate Reconciliation Withholding Tax
EffectiveIncomeTaxRateReconciliationWithholdingTax
0
CY2022 lctx Effective Income Tax Rate Reconciliation Withholding Tax
EffectiveIncomeTaxRateReconciliationWithholdingTax
-0.02
CY2023 lctx Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.01
CY2022 lctx Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.02
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.12
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.28
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.02
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.07
CY2023 us-gaap Effective Income Tax Rate Reconciliation Gilti Percent
EffectiveIncomeTaxRateReconciliationGiltiPercent
0.01
CY2022 us-gaap Effective Income Tax Rate Reconciliation Gilti Percent
EffectiveIncomeTaxRateReconciliationGiltiPercent
0.01
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.08
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.02
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
63461000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
58816000
CY2023Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
8890000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
10463000
CY2023Q4 lctx Deferred Tax Asset Parents And Licenses
DeferredTaxAssetParentsAndLicenses
1606000
CY2022Q4 lctx Deferred Tax Asset Parents And Licenses
DeferredTaxAssetParentsAndLicenses
1500000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3117000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2308000
CY2023Q4 lctx Deferred Tax Asset Operating Lease Liability
DeferredTaxAssetOperatingLeaseLiability
240000
CY2023Q4 lctx Deferred Tax Asset Capitalized Research Expense
DeferredTaxAssetCapitalizedResearchExpense
6217000
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
85238000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
78708000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
80513000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
78209000
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4725000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
499000
CY2023Q4 lctx Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
221000
CY2022Q4 lctx Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
4000
CY2023Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
4771000
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
2464000
CY2023Q4 us-gaap Deferred Tax Liabilities Investment In Noncontrolled Affiliates
DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates
6000
CY2022Q4 us-gaap Deferred Tax Liabilities Investment In Noncontrolled Affiliates
DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates
107000
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
4998000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2575000
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
273000
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
2076000
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
354000
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
2609000
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2963000
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
163100000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
150600000
CY2023 lctx Measurement Period Adjustment Income Tax Expense Benefit
MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit
1100000
CY2022 lctx Measurement Period Adjustment Income Tax Expense Benefit
MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit
1700000
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
1129000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
1047000
CY2023 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
10000
CY2022 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
3000
CY2023 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
54000
CY2022 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
32000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2286000
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
79000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
90000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
830000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
916000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1979000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2860000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2809000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3776000
CY2023Q4 lctx Finance Lease Liability Excluding Other Liabilities Current
FinanceLeaseLiabilityExcludingOtherLiabilitiesCurrent
52000
CY2022Q4 lctx Finance Lease Liability Excluding Other Liabilities Current
FinanceLeaseLiabilityExcludingOtherLiabilitiesCurrent
29000
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
91000
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
84000
CY2022Q4 lctx Other Finance Lease Liabilities Current
OtherFinanceLeaseLiabilitiesCurrent
7000
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
143000
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
120000
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y6M
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y3M18D
CY2023Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y
CY2022Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P4Y1M6D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.065
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.063
CY2023Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.069
CY2022Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.069
CY2023Q1 lctx Insurance Deductable
InsuranceDeductable
25000
CY2023 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.05
CY2022 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.05
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
200000
CY2023 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
200000
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4767000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5673000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8945000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14703000
CY2023Q1 us-gaap Revenues
Revenues
2386000
CY2023Q2 us-gaap Revenues
Revenues
3225000
CY2023Q3 us-gaap Revenues
Revenues
1246000
CY2023Q4 us-gaap Revenues
Revenues
2088000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
8909000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
8122000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
7782000
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
8194000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-6642000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5024000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6705000
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-6362000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4372000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-5229000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-7110000
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-4775000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2022Q1 us-gaap Revenues
Revenues
5237000
CY2022Q2 us-gaap Revenues
Revenues
4553000
CY2022Q3 us-gaap Revenues
Revenues
2998000
CY2022Q4 us-gaap Revenues
Revenues
1915000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
11457000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
8572000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
8014000
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
8452000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-6396000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4234000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5251000
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-6639000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-7087000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-6763000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-6069000
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-6354000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-027988-index-headers.html Edgar Link pending
0000950170-24-027988-index.html Edgar Link pending
0000950170-24-027988.txt Edgar Link pending
0000950170-24-027988-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img7151888_0.jpg Edgar Link pending
img7151888_1.jpg Edgar Link pending
img7151888_2.jpg Edgar Link pending
img7151888_3.jpg Edgar Link pending
img7151888_4.jpg Edgar Link pending
img7151888_5.jpg Edgar Link pending
img7151888_6.jpg Edgar Link pending
img9366389_0.jpg Edgar Link pending
lctx-20231231.htm Edgar Link pending
lctx-20231231.xsd Edgar Link pending
lctx-ex10_04a.htm Edgar Link pending
lctx-ex10_04b.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lctx-20231231_htm.xml Edgar Link completed
lctx-ex21_1.htm Edgar Link pending
lctx-ex23_1.htm Edgar Link pending
lctx-ex31_1.htm Edgar Link pending
lctx-ex31_2.htm Edgar Link pending
lctx-ex32_1.htm Edgar Link pending
lctx-ex97.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending